Incyte stock after-hours at EUR 102.45: minus 1.68 percent versus prior close
Published on 10/02/2026 at 22:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Incyte traded after-hours at EUR 102.45 at 10:51 p.m. CEST on October 2, 2026, down 1.68 percent versus the Lang & Schwarz prior close of EUR 104.20.
After-hours trading
The bid was EUR 102.25 and the ask was EUR 102.65 at the recorded time. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Incyte stock.
Inflammation and autoimmunity data at EADV
Incyte said on September 22, 2026, that data from its inflammation and autoimmunity portfolio would be presented at the European Academy of Dermatology and Venereology 2026 congress in Vienna from September 30 through October 3.
The company said the program covers hidradenitis suppurativa, atopic dermatitis, prurigo nodularis and vitiligo. It includes research on ruxolitinib cream and the investigational treatment povorcitinib, including presentations on phase 3 studies in hidradenitis suppurativa and vitiligo.
